Conducting a COVID-19 drug and vaccine clinical trial

Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:27 (TU)
Créé le avril 17, 2026, 21:27 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-05-01 00:00:00
open_canada_keywords {"fr": ["COVID-19", "pandémie", "essais cliniques", "médicaments", "vaccin", "demande d'autorisation d'essai", "Règlement sur les instruments médicaux", "arrêté provisoire pour essais cliniques de médicaments et de vaccins liés à COVID-19"], "en": ["COVID-19", "pandemic", "clinical trials", "drugs", "vaccine", "apply for a trial authorization", "Medical Devices Regulations", "interim order for clinical trials for drug and vaccine related to COVID-19"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Conduite d'un essai clinique du médicament et du vaccin COVID-19
update_frequency as_needed